Results 321 to 330 of about 1,251,677 (333)

The role of tissue factor pathway inhibitor-2 in cancer biology.

Seminars in Thrombosis and Hemostasis, 2007
E. Sierko, M. Wojtukiewicz, W. Kisiel
semanticscholar   +1 more source

Risk of ovarian function recovery should be considered when switching from treatment with adjuvant tamoxifen to aromatase inhibitor therapy in women with chemotherapy-induced amenorrhea

Ca-A Cancer Journal for Clinicians, 2018
Clement Chung
exaly  

NTRK fusion-positive cancers and TRK inhibitor therapy

Nature Reviews Clinical Oncology, 2018
Emiliano Cocco, Maurizio Scaltriti, Alexander Drilon   +2 more
exaly  

Targeting the PI3K pathway in cancer: are we making headway?

Nature Reviews Clinical Oncology, 2018
Filip Janku, Funda Meric-Bernstam
exaly  

Achieving high energy density and high power density with pseudocapacitive materials

Nature Reviews Materials, 2019
Christopher S Choi, David S Ashby, Danielle M Butts   +2 more
exaly  

Assessment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: A multicenter, randomized, placebo-controlled, single-blind, dose escalation study

Critical Care Medicine, 2001
E. Abraham, K. Reinhart, P. Svoboda, A. Seibert, D. Olthoff, A. D. Dal Nogare, R. Postier, G. Hempelmann, T. Butler, E. Martin, C. Zwingelstein, Sandra R. Percell, V. Shu, A. Leighton, A. Creasey   +14 more
semanticscholar   +1 more source

Protein export through the bacterial Sec pathway

Nature Reviews Microbiology, 2016
Jozefien De Geyter, Anastassios Economou, Spyridoula Karamanou   +2 more
exaly  

Targeting Apoptosis Pathways in Cancer Therapy

Ca-A Cancer Journal for Clinicians, 2005
exaly  

The twin-arginine translocation (Tat) protein export pathway

Nature Reviews Microbiology, 2012
Tracy Palmer, Ben C Berks
exaly  

Targeting the IL-6/JAK/STAT3 signalling axis in cancer

Nature Reviews Clinical Oncology, 2018
Daniel E Johnson, Jennifer R Grandis
exaly